FT Options’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,000
Closed -$13K 297
2017
Q2
$13K Sell
5,000
-38,500
-89% -$4.72M 0.02% 154
2017
Q1
$146K Buy
+43,500
New +$5.21M 0.19% 94
2016
Q4
Sell
-50,000
Closed -$163K 444
2016
Q3
$163K Buy
+50,000
New +$5.41M 0.13% 118
2016
Q1
Sell
-55,700
Closed -$567K 382
2015
Q4
$567K Buy
+55,700
New +$6.44M 0.42% 59

Other funds holding CELG

FT Options's CELG Position: Q3 2017 in Review

FT Options sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 5,000 shares — an estimated $649K sold.

FT Options first reported a position in CELG in Q4 2015 and held it in 2 quarters. The position peaked at $6.57M in Q4 2015. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • FT Options reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • FT Options sold 5,000 Celgene Corp shares in Q3 2017, an estimated $649K.
  • FT Options first reported a position in Celgene Corp in Q4 2015 and held it in 2 quarters.
  • FT Options's Celgene Corp position peaked at $6.57M in Q4 2015.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.